Stability Or Chaos? UK Election Result Increases The Uncertainty For Pharma
Executive Summary
UK industry bodies have expressed concern over the result of the UK general election, as the prime minister decides to form a minority government and EU officials say Brexit talks could be delayed.
You may also be interested in...
July Deadline For EMA Relocation Bids; Member States Begin Scrutiny Of Proposed Hosting Criteria
The criteria that candidates seeking to host the European Medicines Agency post-Brexit will have to meet are out for discussion among member state representatives and should be finalized towards the end of June. Formal bids will have to be in by July end and a decision on the EMA’s new home should be made in October.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.